total
commun
paediatrician
microbiolog
laboratori
studi
clinic
bacteriolog
efficaci
treatment
group
streptococc
pharyng
itali
patient
streptococcu
pyogen
isol
return
follow
still
posit
throat
cultur
erythromycin
resist
er
rate
resist
phenotyp
distribut
constitut
cr
induc
ir
efflux
pump
resist
phenotyp
strain
suscept
blactam
agent
test
cr
strain
highli
resist
member
macrolid
except
rokitamycin
show
activ
isol
phenotyp
ir
isol
suscept
clindamycin
rokitamycin
josamycin
spiramycin
clarithromycin
activ
small
percentag
strain
belong
ir
phenotyp
bacteri
erad
found
penicillin
macrolid
cephalosporin
treat
group
genotyp
strain
show
case
classifi
fail
bacteri
erad
due
recolon
differ
isol
observ
exclus
among
blactam
treat
patient
clinic
cure
achiev
high
percentag
case
irrespect
antibiot
prescrib
best
clinic
efficaci
found
follow
therapi
amoxycillin
clarithromycin
pharyngotonsil
report
caus
mani
virus
bacteria
among
group
bhaemolyt
streptococcu
streptococcu
pyogen
frequent
bacteri
caus
children
sorethroat
posit
cultur
organ
antibiot
treatment
recommend
rhinovriu
adenoviru
coronaviru
respons
acut
pharyngotonsil
caus
group
bhaemolyt
streptococci
often
clinic
indistinguish
viral
infect
therefor
accur
microbiolog
investig
import
untreat
group
infect
organ
persist
caus
seriou
suppur
nonsuppur
complic
aim
antibiot
therapi
therefor
clinic
cure
also
bacteriolog
erad
penicillin
still
gener
consid
drug
choic
found
fail
erad
group
streptococci
children
streptococc
pharingotonsil
even
though
isol
strain
shown
suscept
recent
demonstr
group
streptococc
strain
enter
respiratori
epitheli
cell
becam
inaccess
antibiot
unabl
penetr
cell
membran
penicillin
find
increas
incid
mycoplasma
pneumonia
chlamidia
pneumonia
pathogen
favour
spread
macrolid
use
erythromycin
princip
altern
penicillinallerg
patient
less
streptococcu
pyogen
isol
gener
report
resist
macrolid
antibiot
mark
increas
incid
resist
strain
report
limit
number
countri
name
australia
finland
sweden
uk
japan
taiwan
late
eighti
appreci
resist
macrolid
also
describ
itali
patient
pharyngotonsil
scarlet
fever
recent
nation
survey
confirm
dramat
increas
macrolid
resist
area
countri
incid
macrolid
resist
rise
centr
show
peak
italian
studi
show
similar
result
two
recogn
mechan
resist
macrolid
antibiot
streptococci
target
modif
efflux
system
mechan
give
rise
three
possibl
phenotyp
constitut
induc
call
newli
resist
phenotyp
strain
exhibit
constitut
induc
phenotyp
resist
due
methyl
bacteri
ribosom
phenotyp
isol
found
efflux
system
member
macrolid
appar
distinct
efflux
system
describ
erythromycinresist
staphylococci
aim
studi
follow
children
streptococc
pharyngotonsil
treat
antibiot
chosen
freeli
paediatrician
evalu
clinic
cure
microbiolog
efficaci
differ
therapi
clinic
cure
bacteriolog
erad
determin
correl
evalu
order
distinguish
fail
erad
recolon
treatment
strain
isol
follow
genotyp
studi
plan
open
multicentr
clinicalmicrobiolog
studi
evalu
suscept
streptococcu
bhaemolyt
group
pyogen
isol
pharyng
swab
children
acut
pharyngotonsil
age
year
total
italian
microbiolog
centr
local
microbiolog
centr
commun
paediatrician
involv
patient
receiv
antibiot
therapi
week
prior
studi
exclud
aim
includ
least
paediatr
patient
streptococc
pharyngotonsil
pharyng
cultur
antibiot
treatment
investig
coordin
neonat
patholog
depart
pavia
univers
microbiolog
institut
milan
univers
first
visit
patient
paediatrician
would
complet
casereportform
histori
sign
symptom
suspect
infect
prescrib
antibiot
therapi
would
regist
clinic
diagnosi
bacteri
pharyngotonsil
would
establish
take
account
brees
score
antibiot
therapi
would
chosen
freeli
physician
pharyng
swab
taken
therapi
togeth
casereport
form
sent
local
microbiolog
centr
cultur
isol
strain
store
glycerol
sent
central
laboratori
microbiolog
cultur
neg
antibiot
therapi
stop
cultur
posit
group
streptococci
second
visit
day
last
day
antibiot
treatment
organ
paediatrician
would
complet
second
casereportform
detail
antibiot
therapi
clinic
evalu
case
second
pharyng
swab
would
taken
sent
local
microbiolog
centr
identif
clinic
judgement
would
use
describ
patient
clinic
cure
improv
exhibit
treatment
failur
patient
said
clinic
cure
symptom
disappear
followup
improv
one
symptom
even
minor
except
fever
still
present
classifi
treatment
failur
fever
one
symptom
still
present
local
microbiolog
centr
streptococc
strain
isol
identifi
disc
suscept
test
variou
antibiot
perform
strain
label
code
identif
number
store
plate
frozen
brainheartinfus
broth
ad
glycerol
sent
everi
day
central
laboratori
casereportform
central
laboratori
strain
reidentifi
mic
determin
erythromycin
azithromycin
clarithromycin
roxithromycin
rokitamycin
josamycin
spiramycin
clindamycin
amoxycillin
amoxycillin
clavulan
acid
cefotaxim
tetracyclin
phenotyp
erythromycin
resist
strain
determin
genotyp
isol
case
posit
followup
order
distinguish
nonerad
recolon
pharyng
swab
immedi
cultur
columbia
cnabas
blood
agar
plate
contain
sheep
blood
marcyletoil
franc
strain
identif
perform
bacitracin
disc
difco
laboratori
detroit
mi
either
latex
agglutin
assay
streptex
wellcom
dartford
uk
latexagglutin
group
kit
streptoslid
dioess
diagnostica
senes
srl
suscept
pyogen
isol
initi
evalu
disc
diffus
method
accord
nccl
perform
standard
antibiot
disc
suppli
oxoid
unipath
basingstok
except
azithromycin
rokitamycin
becton
dickinson
meylan
franc
strain
reidentifi
central
microbiolog
laboratori
method
alreadi
describ
minimum
inhibitori
concentr
antibiot
determin
microdilut
method
describ
nccl
guidelin
cation
adjust
mueller
hinton
broth
difco
use
supplement
lyse
hors
blood
oxoid
contain
doubl
dilut
antibiot
test
streptococc
isol
thaw
inocul
bhi
broth
incub
h
allow
bacteria
reach
exponenti
growth
phase
cultur
dilut
obtain
final
bacteri
inoculum
cfuml
total
volum
mlwell
pyogen
atcc
use
control
mic
valu
record
follow
h
incub
mic
defin
antibiot
concentr
first
well
ie
well
lowest
antibiot
concentr
support
visibl
growth
test
result
interpret
accord
nccl
criteria
antibiot
breakpoint
avail
macrolideresist
phenotyp
determin
erythromycinresist
er
isol
modif
method
describ
seppala
et
al
use
two
disc
contain
erythromycin
mg
clindamycin
mg
disc
oxoid
disc
place
mm
apart
blood
agar
plate
mueller
hinton
agar
supplement
hors
blood
inocul
bacteri
suspens
follow
overnight
incub
inhibit
zone
around
two
disc
observ
blunt
clindamycin
zone
inhibit
proxim
erythromycin
disc
indic
induc
resist
ir
phenotyp
resist
erythromycin
clindamycin
blunt
clindamycin
inhibit
zone
indic
constitut
resist
cr
phenotyp
resist
phenotyp
describ
phenotyp
character
resist
erythromycin
suscept
clindamycin
blunt
zone
around
clindamycin
disc
bacteri
cultur
ml
earli
stationari
phase
cell
pellet
centrifug
rpm
min
wash
ml
piv
buffer
mm
tri
ph
nacl
resuspend
ml
buffer
concentr
adjust
od
cell
suspens
dilut
ml
lowgellingtemperatur
agaros
pharmacia
biotech
uppsala
sweden
piv
buffer
agaros
disc
ml
prepar
allow
solidifi
min
cell
lyse
incub
disc
h
ml
ec
lysi
buffer
mm
tri
ph
nacl
edta
ph
sodium
deoxychol
sarkosyl
mgl
rnase
mgml
lysozym
sigma
disc
incub
h
es
buffer
edta
ph
contain
mgml
proteinas
k
wash
four
time
ml
te
buffer
mm
tri
ph
mm
edta
ph
gentl
agit
h
agaros
disc
consid
contain
purifi
dna
store
te
prior
electrophoresi
agaros
disc
allow
equilibr
ml
restrict
buffer
mm
tri
ph
mm
kcl
mm
mgcl
mm
room
temperatur
min
follow
restrict
h
ml
restrict
buffer
contain
bovin
serum
albumin
bsa
mgml
uml
smai
pharmacia
biotech
reaction
stop
ml
es
buffer
ml
load
buffer
electrophoresi
gel
prepar
use
agaros
pharmacia
biotech
tbe
buffer
mm
trisbor
mm
edta
disc
contain
digest
dna
load
gel
seal
lowgellingtemperatur
agaros
two
molecularweight
marker
use
lambda
ladder
kb
lowrang
kb
puls
field
gel
marker
sigma
pulsefield
gel
electrophoresi
perform
use
gene
navig
system
apparatu
pharmacia
biotech
run
condit
v
h
puls
time
h
h
h
last
h
gel
visual
photograph
follow
ethidium
bromid
stain
uv
light
interpret
dna
restrict
pattern
gener
pulsefield
gel
electrophoresi
use
guidelin
propos
tenov
et
al
dna
restrict
pattern
isol
differ
three
restrict
fragment
consid
belong
differ
clonal
type
pharyng
swab
posit
pyogen
case
first
visit
baselin
case
second
visit
followup
antibiot
therapi
continu
case
posit
pharyng
swab
use
paediatrician
prescript
daili
dosag
durat
tabl
show
number
strain
isol
laboratori
particip
centr
total
baselin
isol
erythromycinsuscept
es
erythromycinresist
er
cr
phenotyp
ir
phenotyp
phenotyp
strain
irrespect
suscept
erythromycin
show
mic
amoxycillin
amoxycillin
plu
clavulan
acid
cefotaxim
rang
mgl
mic
distribut
test
agent
express
cumul
percentag
subdivid
accord
differ
suscept
phenotyp
report
tabl
esstrain
suscept
antibiot
test
except
tetracyclin
strain
found
resist
erstrain
suscept
penicillin
cefotaxim
variabl
tetracyclin
resist
strain
cr
phenotyp
highli
resist
azithromycin
roxithromycin
nonact
whilst
clarithromycin
found
activ
small
percentag
strain
belong
ir
phenotyp
rokitamycin
although
breakpoint
avail
suscept
result
show
mic
mgl
cr
strain
mic
mgl
ir
phenotyp
higher
incid
erstrain
tabl
regist
pinerolo
follow
napoli
mantova
catanzaro
two
centr
abbiategrasso
sondalo
isol
resist
strain
macrolid
resist
italian
territori
thu
describ
patchi
distribut
total
case
present
followup
show
bacteri
erad
still
posit
tabl
report
clinic
bacteriolog
result
follow
treatment
major
group
antibiot
use
treatment
infect
patient
penicillin
clarithromycin
gave
best
bacteri
erad
result
respect
follow
amoxycillin
plu
clavulan
acid
oral
cephalosporin
macrolid
erad
percentag
rang
rokitamycin
clarithromycin
highest
percentag
microbiolog
failur
regist
rokitamycin
nonerad
microorgan
mic
mgl
baselin
therapi
tabl
show
bacteri
erad
follow
macrolid
treatment
agent
least
evalu
patient
accord
suscept
baselin
isol
erythromycin
bacteri
erad
es
er
baselin
isol
follow
clarithromycin
treatment
follow
azithromycin
rokitamycin
phenotyp
er
isol
erad
follow
macrolid
treatment
ident
baselin
strain
clarithromycin
cr
ir
phenotyp
azithromycin
cr
ir
phenotyp
rokitamycin
cr
ir
phenotyp
interestingli
azithromycin
treat
group
four
erythromycin
suscept
strain
baselin
mic
mgl
erad
becam
er
follow
treatment
three
exhibit
phenotyp
mic
mgl
one
ir
phenotyp
mic
mgl
genotypeidentif
strain
isol
baselin
followup
allow
us
distinguish
nonerad
recolon
antibiot
treatment
group
result
report
tabl
basi
genotyp
found
strain
isol
follow
belong
macrolid
cefaclor
ceftibuten
ceftriaxon
treat
group
confirm
true
failur
erad
hand
amoxycillin
amoxycillin
clavulan
acid
cefixim
cefuroxim
axetil
case
fail
erad
shown
due
recolon
differ
strain
consid
patient
posit
baselin
recurr
episod
pharyngotonsil
report
case
ear
infect
four
rheumat
fever
correl
symptom
presenc
concomit
diseas
report
case
patient
treat
antibiot
last
day
patient
age
year
age
year
age
followup
visit
perform
mean
period
day
end
antibiot
treatment
symptom
infect
fever
sore
throat
evalu
baselin
followup
tabl
give
major
antibiot
therapi
chosen
paediatrician
well
clinic
bacteriolog
result
clinic
cure
achiev
patient
improv
failur
subject
irrespect
antibiot
treatment
receiv
data
clinic
evalu
avail
patient
tabl
give
detail
microbiolog
evalu
clinic
cure
penicillin
rang
amoxycillin
clavulan
acid
penicillin
ampicillin
amoxycillin
oral
cephalosporin
clinic
cure
achiev
patient
rang
cefaclor
cefixim
macrolid
clinic
cure
rang
rokitamycin
clarithromycin
complic
infect
aden
pharyng
abscess
occur
case
advers
event
usual
affect
skin
gastrointestin
tract
aim
antibiot
therapi
treatment
pharyngotonsil
clinic
cure
bacteriolog
erad
avoid
rare
seriou
poststreptococc
sequela
studi
shown
erythromycin
resist
rate
itali
rel
high
uniformli
distribut
nation
territori
common
type
macrolid
resist
pyogen
found
due
recent
describ
efflux
pump
streptococci
specif
mem
clinic
cure
achiev
high
percentag
case
irrespect
antibiot
prescrib
best
clinic
efficaci
achiev
follow
therapi
amoxycillin
clarithromycin
oral
cephalosporin
give
clinic
cure
bacteri
erad
similar
clarithromycin
penicillin
respect
spite
higher
resist
rate
clarithromycin
convers
rokitamycin
markedli
better
vitro
activ
respect
macrolid
test
show
lowest
erad
rate
interestingli
studi
demonstr
treatment
azithromycin
abl
select
resist
strain
pyogen
four
case
fail
erad
follow
azithromycin
therapi
found
isol
chang
suscept
mic
mgl
resist
phenotyp
ir
mic
mgl
follow
therapi
contrast
clarithromycin
treat
case
found
chang
suscept
pattern
strain
isol
therapi
genotyp
strain
isol
prior
therapi
also
provid
use
inform
concern
true
bacteri
erad
distinguish
case
due
bacteri
recolon
would
otherwis
wrongli
classifi
microbiolog
failur
exampl
microbiolog
failur
cephalosporin
cefixim
cefuroxim
axetil
recolon
therapi
found
occur
respect
case
macrolid
howev
microbiolog
failur
confirm
due
fail
bacteri
erad
case
bacteri
recolon
gener
true
fail
bacteri
erad
case
receiv
therapi
blactam
agent
may
attribut
presenc
recent
describ
intern
gene
group
streptococci
higher
percentag
true
fail
erad
rate
amoxycillinclavulan
acid
respect
amoxycillin
therapi
alon
could
either
due
presenc
intern
gene
higher
proport
isol
treat
combin
agent
poor
complianc
view
poor
tast
formulationw
thank
pediatrician
local
microbiologist
made
possibl
execut
studi
tabl
bacteri
erad
versu
recolon
basi
genotyp
identif
pyogen
strain
isol
baselin
followup
